| 000 | 03234nam a22003735i 4500 | ||
|---|---|---|---|
| 001 | 233315 | ||
| 003 | ES-VaUE | ||
| 005 | 20221220020451.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 201119s2021 xxu| s |||| 0|eng d | ||
| 020 | _a9781071608388 | ||
| 024 | 7 |
_a10.1007/978-1-0716-0838-8 _2doi |
|
| 040 |
_aES-MaUEC _bspa _cES-MaUEC |
||
| 245 | 1 | 0 |
_aNanomedicines for Brain Drug Delivery _cedited by Javier O. Morales, Pieter J. Gaillard. |
| 250 | _a1st edition 2021 | ||
| 264 | 1 |
_aNew York, NY _bSpringer International Publising _c2021 |
|
| 300 |
_a1 recurso en línea (XII, 280 páginas) _b33 ilustraciones, 27 ilustraciones a color |
||
| 336 |
_atexto _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 347 |
_aarchivo de texto _bPDF |
||
| 490 | 0 |
_aNeuromethods _x1940-6045 _v157 |
|
| 505 | 0 | _aBiodegradable Polymeric Nanoparticles for Brain-Targeted Drug Delivery -- Liposomes as Brain Targeted Delivery Systems -- Nanofibres and Nanostructured Scaffolds for Nervous System Lesions -- Self-Assembling Peptide Nanofibrous Scaffolds in Central Nervous System Lesions -- The Use of Peptide and Protein Vectors to Cross the Blood Brain Barrier for the Delivery of Therapeutic Concentration of Biologics -- Inorganic Nanoparticles and Their Strategies to Enhance Brain Drug Delivery -- Magnetic Nanoparticles as Delivery Systems to Penetrate the Blood Brain Barrier -- Nose-to-Brain Drug Delivery Enabled by Nanocarriers -- In Vitro Models of Central Nervous System Barriers for Blood Brain Barrier Permeation Studies -- Safety and Nanotoxicity Aspects of Nanomedicines for Brain-Targeted Drug Delivery. | |
| 520 | _aThis volume explores the latest research in central nervous system (CNS) targeted nanocarriers, methods for their synthesis, and its characterization process. Chapters in this book cover topics such as polymeric nanoparticles and liposomes; self-assembled peptide-based scaffolds for lesions of the nervous system; use of peptides as CNS drugs and as potential carriers to optimize brain-targeted delivery; ways to model and assess blood brain barrier absorption of drugs; and the role of neurodegeneration progress of nanomaterials and their potential toxicity concerns. In the Neuromethods series style, chapters include the kind of detail and key advice from the specialists needed to get successful results in your laboratory. Thorough and cutting-edge, Nanomedicines for Brain Drug Delivery is a valuable resource that will help researchers guide and advance the field of nanomedicines for the brain and nervous system. | ||
| 700 | 1 |
_aMorales, Javier O _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
| 700 | 1 |
_aGaillard, Pieter J _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
| 776 | 0 | 8 |
_iPrinted edition: _z9781071608371 |
| 776 | 0 | 8 |
_iPrinted edition: _z9781071608395 |
| 776 | 0 | 8 |
_iPrinted edition: _z9781071608401 |
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-1-0716-0838-8 _z(usuarios Universidad Europea de Valencia) |
| 942 |
_2lcc _cLE |
||
| 988 | _aSpringer_Protocols_2021 | ||
| 999 |
_c233315 _d233315 |
||